More than 99% of drug trials for Alzheimer’s Disease during the past decade have failed. An article in the Alzheimer’s Research & Therapy journal discusses an issue which was perhaps the key focus of the Global Dementia Legacy Event. Only one new medicine has been approved since 2004; 99.6% of drug trials aimed at preventing, curing or improving the symptoms of Alzheimer’s Disease between 2002 and 2012 either failed or were discontinued.
Briggs, H. (2014). Decline in trials for Alzheimer’s disease. London: BBC Health News, July 3rd 2014.
This relates to:
Cummings, JL. Morstorf, T. [and] Zhong, K. (2014). Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimer’s Research & Therapy, July 3rd 2014. 6: 37.
[A version of this item features in Dementia: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 12, July 2014].